Trial in Progress (TiP) - neoadjuvant immunotherapy of visugromab (anti-GDF-15; CTL-002) in combination with nivolumab in Muscle-Invasive Bladder Cancer (MIBC)

Saved in:
Bibliographic Details
Published in:European urology 2023-02, Vol.83, p.S750
Main Authors: Necchi, A., Iacovelli, R., Di Maio, M., Gontero, P., Fettes, P., Klar, K., Hermann, F., Leo, E.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0302-2838
DOI:10.1016/S0302-2838(23)00570-5